Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar rats

High fat diet (HFD) is a risk factor for metabolic syndrome which is characterized by overt glucose dysmetabolism and tissue derangement. The liver and pancreas are important metabolic tissues with anatomical proximity sharing splanchnic and mesenteric circulation but it is unclear whether, there is...

Full description

Bibliographic Details
Main Authors: Oluwaseun A. Adeyanju, Olabimpe C. Badejogbin, Damilare E. Areola, Kehinde S. Olaniyi, Chinaza Dibia, Olaniyi A. Soetan, Adesola A. Oniyide, Olugbenga S. Michael, Lawrence A. Olatunji, Ayodele O. Soladoye
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332220311860
id doaj-ba746d3201ad4b57850ef56ce6f84d90
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Oluwaseun A. Adeyanju
Olabimpe C. Badejogbin
Damilare E. Areola
Kehinde S. Olaniyi
Chinaza Dibia
Olaniyi A. Soetan
Adesola A. Oniyide
Olugbenga S. Michael
Lawrence A. Olatunji
Ayodele O. Soladoye
spellingShingle Oluwaseun A. Adeyanju
Olabimpe C. Badejogbin
Damilare E. Areola
Kehinde S. Olaniyi
Chinaza Dibia
Olaniyi A. Soetan
Adesola A. Oniyide
Olugbenga S. Michael
Lawrence A. Olatunji
Ayodele O. Soladoye
Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar rats
Biomedicine & Pharmacotherapy
Pancreas
Short chain fatty acids
NAFLD
Uric acid
High fat diet
author_facet Oluwaseun A. Adeyanju
Olabimpe C. Badejogbin
Damilare E. Areola
Kehinde S. Olaniyi
Chinaza Dibia
Olaniyi A. Soetan
Adesola A. Oniyide
Olugbenga S. Michael
Lawrence A. Olatunji
Ayodele O. Soladoye
author_sort Oluwaseun A. Adeyanju
title Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar rats
title_short Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar rats
title_full Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar rats
title_fullStr Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar rats
title_full_unstemmed Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar rats
title_sort sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed wistar rats
publisher Elsevier
series Biomedicine & Pharmacotherapy
issn 0753-3322
publishDate 2021-01-01
description High fat diet (HFD) is a risk factor for metabolic syndrome which is characterized by overt glucose dysmetabolism and tissue derangement. The liver and pancreas are important metabolic tissues with anatomical proximity sharing splanchnic and mesenteric circulation but it is unclear whether, there is an associated metabolic status between the two organs in health and disease. Uric acid (UA) hypersecretion and ectopic lipid accumulation are characteristic pathophysiology of an array of non-communicable diseases. Sodium butyrate (BUT) is reputed for therapeutic roles in metabolic derangement. Therefore, the present study investigated synchrony in hepatic and pancreatic UA and lipid metabolic status in HFD-induced glucose dysregulation and probed the beneficial effects of BUT. Twenty-four female Wistar rats were treated with normal rat chow and distilled water (po) or sodium butyrate (200 mg/kg; po) or high fat diet and distilled water (po) or high fat diet and sodium butyrate. Results showed that HFD increased plasma, pancreatic and hepatic triglyceride, triglyceride-glucose index, malondialdehyde, uric acid (UA), lactate dehydrogenase but reduced glucose-6-phosphate dehydrogenase. Histological analysis revealed hepatic and pancreatic architectural derangement and cellular degeneration in HFD-fed animals. However, BUT reversed the HFD-induced systemic, pancreatic and hepatic synchronous dysmetabolism with evidence of improved histology. HFD-induced lipid and UA alterations were synchronous in the pancreas and liver. BUT elicits beneficial effects on systemic and tissue HFD-induced deleterious metabolic changes which were synchronized in pancreas and liver of rats.
topic Pancreas
Short chain fatty acids
NAFLD
Uric acid
High fat diet
url http://www.sciencedirect.com/science/article/pii/S0753332220311860
work_keys_str_mv AT oluwaseunaadeyanju sodiumbutyratearrestspancreatohepaticsynchronousuricacidandlipiddysmetabolisminhighfatdietfedwistarrats
AT olabimpecbadejogbin sodiumbutyratearrestspancreatohepaticsynchronousuricacidandlipiddysmetabolisminhighfatdietfedwistarrats
AT damilareeareola sodiumbutyratearrestspancreatohepaticsynchronousuricacidandlipiddysmetabolisminhighfatdietfedwistarrats
AT kehindesolaniyi sodiumbutyratearrestspancreatohepaticsynchronousuricacidandlipiddysmetabolisminhighfatdietfedwistarrats
AT chinazadibia sodiumbutyratearrestspancreatohepaticsynchronousuricacidandlipiddysmetabolisminhighfatdietfedwistarrats
AT olaniyiasoetan sodiumbutyratearrestspancreatohepaticsynchronousuricacidandlipiddysmetabolisminhighfatdietfedwistarrats
AT adesolaaoniyide sodiumbutyratearrestspancreatohepaticsynchronousuricacidandlipiddysmetabolisminhighfatdietfedwistarrats
AT olugbengasmichael sodiumbutyratearrestspancreatohepaticsynchronousuricacidandlipiddysmetabolisminhighfatdietfedwistarrats
AT lawrenceaolatunji sodiumbutyratearrestspancreatohepaticsynchronousuricacidandlipiddysmetabolisminhighfatdietfedwistarrats
AT ayodeleosoladoye sodiumbutyratearrestspancreatohepaticsynchronousuricacidandlipiddysmetabolisminhighfatdietfedwistarrats
_version_ 1721432909524500480
spelling doaj-ba746d3201ad4b57850ef56ce6f84d902021-05-21T04:19:09ZengElsevierBiomedicine & Pharmacotherapy0753-33222021-01-01133110994Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar ratsOluwaseun A. Adeyanju0Olabimpe C. Badejogbin1Damilare E. Areola2Kehinde S. Olaniyi3Chinaza Dibia4Olaniyi A. Soetan5Adesola A. Oniyide6Olugbenga S. Michael7Lawrence A. Olatunji8Ayodele O. Soladoye9Cardiometabolic Research Unit, Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti, Nigeria; HOPE Cardiometabolic Research Team & Department of Physiology, University of Ilorin, Ilorin, Nigeria; Corresponding author at: Department of Physiology, Afe Babalola University, P.M.B. 5454, Ado-Ekiti, 360101, Nigeria.Cardiometabolic Research Unit, Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti, NigeriaHOPE Cardiometabolic Research Team & Department of Physiology, University of Ilorin, Ilorin, Nigeria; Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, NigeriaCardiometabolic Research Unit, Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti, Nigeria; HOPE Cardiometabolic Research Team & Department of Physiology, University of Ilorin, Ilorin, NigeriaHOPE Cardiometabolic Research Team & Department of Physiology, University of Ilorin, Ilorin, Nigeria; Department of Physiology, Nnamdi Azikiwe University, Awka, Anambra State, NigeriaHOPE Cardiometabolic Research Team & Department of Physiology, University of Ilorin, Ilorin, NigeriaCardiometabolic Research Unit, Department of Physiology, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti, NigeriaHOPE Cardiometabolic Research Team & Department of Physiology, University of Ilorin, Ilorin, Nigeria; Cardiometabolic Research Unit, Department of Physiology, College of Health Sciences, Bowen University, Iwo, NigeriaHOPE Cardiometabolic Research Team & Department of Physiology, University of Ilorin, Ilorin, Nigeria; Department of Physiology, College of Health Sciences, University of Ilorin, Ilorin, NigeriaCardiometabolic Research Unit, Department of Physiology, College of Health Sciences, Bowen University, Iwo, NigeriaHigh fat diet (HFD) is a risk factor for metabolic syndrome which is characterized by overt glucose dysmetabolism and tissue derangement. The liver and pancreas are important metabolic tissues with anatomical proximity sharing splanchnic and mesenteric circulation but it is unclear whether, there is an associated metabolic status between the two organs in health and disease. Uric acid (UA) hypersecretion and ectopic lipid accumulation are characteristic pathophysiology of an array of non-communicable diseases. Sodium butyrate (BUT) is reputed for therapeutic roles in metabolic derangement. Therefore, the present study investigated synchrony in hepatic and pancreatic UA and lipid metabolic status in HFD-induced glucose dysregulation and probed the beneficial effects of BUT. Twenty-four female Wistar rats were treated with normal rat chow and distilled water (po) or sodium butyrate (200 mg/kg; po) or high fat diet and distilled water (po) or high fat diet and sodium butyrate. Results showed that HFD increased plasma, pancreatic and hepatic triglyceride, triglyceride-glucose index, malondialdehyde, uric acid (UA), lactate dehydrogenase but reduced glucose-6-phosphate dehydrogenase. Histological analysis revealed hepatic and pancreatic architectural derangement and cellular degeneration in HFD-fed animals. However, BUT reversed the HFD-induced systemic, pancreatic and hepatic synchronous dysmetabolism with evidence of improved histology. HFD-induced lipid and UA alterations were synchronous in the pancreas and liver. BUT elicits beneficial effects on systemic and tissue HFD-induced deleterious metabolic changes which were synchronized in pancreas and liver of rats.http://www.sciencedirect.com/science/article/pii/S0753332220311860PancreasShort chain fatty acidsNAFLDUric acidHigh fat diet